Condition: Erectile Dysfunction With Diabetes Mellitus · Sponsor: Aswan University Hospital
Study is aiming to evaluate safety, efficacy and durability of intracavernosal injection (ICI) of Botulinum toxin A plus oral tadalafil in controlled diabetic men with refractory Erectile Dysfunction.
This description comes directly from the study's public registry record.
Hossam-Eldin Hosny Ahmed Awad, Professor · 01001666093 · sombok@yahoo.com
Moustafa Adam Ali, Professor · 01092991101 · moustafa.eltaib@aswu.edu.eg
Always discuss trial participation with your own doctor first.
| Aswan University-Faculty of Medicine | Aswān, Aswan Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06583590